Map of malaria behaviour set to revolutionise research
The Malaria Cell Atlas gives the highest resolution view of malaria parasite gene expression to date and monitors how individual parasites change as they develop in both the mosquito and human host
The first detailed map of individual malaria parasite behaviour across each stage of its complicated life cycle has been created by scientists. Researchers at the Wellcome Sanger Institute and their collaborators used advanced single-cell technology to isolate individual parasites and measure their gene activity. The result is the Malaria Cell Atlas, which gives the highest resolution view of malaria parasite gene expression to date and monitors how individual parasites change as they develop in both the mosquito and human host.
Reported today (22 August) in Science, the team also pinpoint particular stages in the life cycle where each malaria parasite gene is likely to play a key role in parasite development. Knowing when and where a gene is active presents possible targets in the malaria life cycle that are important for developing much-needed antimalarial drugs, vaccines, and transmission blocking strategies.
Malaria affects more than 200 million people worldwide and caused nearly 450,000 deaths in 2017, the majority of which were children under five*. The malaria parasite’s ability to become resistant to multiple frontline drugs poses an enormous threat to malaria control. While advances are being made in vaccine development, a barrier to discovering new malaria drugs is the fact that the function of nearly half of the parasite’s genes are unknown.
Understanding the diverse behaviours and gene activities of malaria parasites across their complicated life cycle is now possible with the freely available Malaria Cell Atlas data resource, created by scientists at the Wellcome Sanger Institute.
“We’ve created an atlas of gene activity that spans the complete life cycle of the malaria parasite. This is the first atlas of its kind for a single-cell organism. The malaria parasite’s life cycle is key to research into this disease and the Malaria Cell Atlas will help us truly understand the parasite in order to effectively control malaria.”
Dr Virginia Howick Joint first author from the Wellcome Sanger Institute
To create the map, the team isolated and measured the gene activity of 1,787 individual malaria parasites from 10 stages across the complete life cycle, spanning both the human and the mosquito. For example, the researchers gave mosquitoes infected with malaria a fake blood meal to capture the parasites they released in their spit in order to compare them to parasites that remained in the salivary glands.
The team then measured which genes were active in individual parasites across the entire life cycle. Knowing which genes are critical in each stage of the parasite’s life cycle presents weak spots and future drug targets.
By looking at the activity of previously studied genes that showed similar patterns of activity to the 40 per cent of genes that currently have no known function, the team could infer potential functions for these unknown genes.
“Using the Malaria Cell Atlas, we’ve inferred the roles of parasite genes that until now were entirely unknown. We do this through ‘guilt-by-association’: by looking at functions of previously studied genes, we can predict roles of unknown genes if they show similar activity patterns to known genes. This provides a new opportunity to find novel drug targets.”
Andrew Russell Joint first author and a PhD student at the Wellcome Sanger Institute
The team expanded the Malaria Cell Atlas by using another single-cell technology to examine a further 16,000 individual parasites from the blood stages of malaria that infect mice, monkeys and humans. This showed similar gene activity behaviour across the three malaria parasite species even though they infect such different hosts. Identifying genes that are essential in multiple species of malaria helps towards building new candidate drug targets, as these targets might be effective in all five of the malaria species that infect humans.
Researchers then collected parasites present in the blood of three Kenyan people who were infected with malaria, just as they were being treated for the disease. Using the Malaria Cell Atlas as a reference, the team were able to examine individual “wild” parasites from two different human malaria parasite species for the first time. This opens the door to understanding which genes are active in natural infections in the real world, and how these might differ to malaria parasites cultured in the laboratory.
“To defeat malaria we need to understand all the tricks the parasite uses throughout its life cycle. The Malaria Cell Atlas is the first detailed map that gives us insight into how different one parasite is from another, even when they are genetically identical. We face the problem of malaria becoming more resistant to current malaria drugs, and as new drugs are introduced, we hope the Malaria Cell Atlas will act as a reference to understand how parasites change their behaviours in response to our efforts to control them. Knowing this will help reveal how to corner the parasites and ultimately eliminate them.”
Dr Mara Lawniczak Lead author from the Wellcome Sanger Institute
Virginia Howick, Andrew Russell et al. (2019) The Malaria Cell Atlas: single parasite transcriptomes across the complete Plasmodium life cycle. Science. DOI: 10.1126/science.aaw2619
This study was supported by Wellcome (206194/Z/17/Z; 107372), MRC (G1100339), Danish institute of Advanced Study, University of Southern Denmark, UK Department for International Development, Swedish International Development Cooperation Agency, Swiss Agency for Development and Cooperation, German Academic Exchange Service, Kenyan government, NIH/NIAID (R01AI137154).
The Wellcome Sanger Institute is a world-leading genomics research centre. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data, results, tools and technologies are shared across the globe to advance science. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. Find out more at www.sanger.ac.uk or follow us on Twitter, Facebook, LinkedIn and on our Blog.
Wellcome exists to improve health by helping great ideas to thrive. We support researchers, we take on big health challenges, we campaign for better science, and we help everyone get involved with science and health research. We are a politically and financially independent foundation. https://wellcome.org/
Related blog posts
22 Aug 2019
Malaria Cell Atlas: mapping a murderous parasite’s life cycle
Malaria - and the parasite that causes it - is complicated. Not only does the single-celled parasite move between humans and mosquitoes, but ...
1 Dec 2017
Life in the fast lane: rapid reproduction in malaria parasites
1.12.17 Brandon Invergo investigates how quickly malaria parasites can prepare to sexually reproduce once they are picked up by ...
31 Oct 2017
A step towards an effective, multi-target vaccine for malaria
Gareth Powell and Leyla Bustamante helped to find five targets on the parasite that could be the basis of a new ...
13 Jul 2017
Malaria parasites: more susceptible to a knock-out blow than we thought?
13.7.17 Theo Sanderson and Ellen Bushell explain how characterising the role of many of the malaria parasite’s five ...
What is malaria?
Spread by mosquitos, malaria is one of the most common infectious diseases and a global public health challenge.
Life in the Lab: working in a malaria lab
This film shows how scientists work with malaria parasites in the lab; culturing parasites and preparing them so they can be ...
12 Apr 2021
New genetic drug target for treatment resistant colorectal cancer
Researchers have identified a new potential drug target for treating some types of advanced colorectal cancers.
7 Apr 2021
‘Patchwork’ tumours prevalent across multiple cancer types
Scientists have confirmed that tumour evolution is driven by changes that benefit the cancer, and these lead to a wide range ...